Biomedical Engineering Reference
In-Depth Information
31. Jain, R. K., Au, P., Tam, J., and Fukumura, D. 2005. Engineering vascularized tissue. Nat
Biotechnol 23: 821-823.
32. Johnson, P. C., Mikos, A. G., Fisher, J. P., and Jansen, J. A. 2007. Strategic directions in tissue
engineering. Tissue Eng 13: 2827-2837.
33. Carino, G. P. and Mathiowitz, E. 1999. Oral insulin delivery. Adv Drug Deliv Rev 35: 249-257.
34. Graves, P. M. and Eisenbarth, G. S. 1999. Pathogenesis, prediction and trials for the prevention
of insulin-dependent (type 1) diabetes mellitus. Adv Drug Deliv Rev 35: 143-156.
35. Krauland, A. H., Guggi, D., and Bernkop-Schnurch, A. Oral insulin delivery: The potential of
thiolated chitosan-insulin tablets on non-diabetic rats. J Control Release 95: 547-555.
36. Pan, Y, Li, Y. J., Zhao, H. Y., Zheng, J. M., Xu, H., Wei, G., Hao, J. S., and Cui, F. D. 2002.
Bioadhesive polysaccharide in protein delivery system: Chitosan nanoparticles improve the
intestinal absorption of insulin in vivo. Int J Pharm 249: 139-147.
37. Cano-Cebrian, M. J., Zornoza, T., Granero, L., and Polache, A. 2005. Intestinal absorption
enhancement via the paracellular route by fatty acids, chitosans and others: A target for drug
delivery. Curr Drug Deliv 2: 9-22.
38. Avadi, M. R., Jalali, A., Sadeghi, A. M. M., Shamimi, K., Bayati, K. H., Nahid, E., Dehpour, A. R.,
and Rafiee-Tehrani, M. 2005. Diethyl methyl chitosan as an intestinal paracellular enhancer: Ex
vivo and in vivo studies. Int J Pharm 293: 83-89.
39. Xu, Y., Du, Y., Huang, R., and Gao, L. P. 2003. Preparation and modification of N -(2-hydroxyl)
propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier. Biomaterials
24: 5015-5022.
Search WWH ::




Custom Search